Authors: Pandolfino, MC Labarriere, N Tessier, MH Cassidanius, A Bercegeay, S Lemarre, P Dehaut, F Dreno, B Jotereau, F

Citation: Mc. Pandolfino et al., High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, CANCER IMMU, 50(3), 2001, pp. 134-140

Authors: Benlalam, H Labarriere, N Linard, B Derre, L Diez, E Pandolfino, MC Bonneville, M Jotereau, F

Citation: H. Benlalam et al., Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, EUR J IMMUN, 31(7), 2001, pp. 2007-2015

Authors: Gervois, N Labarriere, N Le Guiner, S Pandolfino, MC Fonteneau, JF Guilloux, Y Diez, E Dreno, B Jotereau, F

Citation: N. Gervois et al., High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, CLIN CANC R, 6(4), 2000, pp. 1459-1467

Authors: Moreau-Aubry, A Le Guiner, S Labarriere, N Gesnel, MC Jotereau, F Breathnach, R

Citation: A. Moreau-aubry et al., A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma, J EXP MED, 191(9), 2000, pp. 1617-1623

Authors: Pellat-Deceunynck, C Mellerin, MP Labarriere, N Jego, G Moreau-Aubry, A Harousseau, JL Jotereau, F Bataille, R

Citation: C. Pellat-deceunynck et al., The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressedby human myeloma cells, EUR J IMMUN, 30(3), 2000, pp. 803-809